http://elpais.com
el ajuste sanitario
スペインの医療費削減で、重症でない薬の薬代は、処方せんなしで、全額負担
Fármacos para síntomas poco graves dejan de financiarse
El sector teme que queden fuera laxantes, mucolíticos y algunos analgésicos
sanitary adjustment
Drugs for severe symptoms soon cease to be financed
The industry fears that lie beyond laxatives, mucolytics and some painkillers
All measures of the decree on health
Emilio de Benito Madrid 24 ABR 2012 - 22:02 CET
Drugs for severe symptoms soon cease to be financed
The industry fears that lie beyond laxatives, mucolytics and some painkillers
All measures of the decree on health
Emilio de Benito Madrid 24 ABR 2012 - 22:02 CET
The drugs will provide the bulk of the savings plan set by the Government. The royal decree was issued Tuesday establishing a mechanism to take public financing certain products. These are drugs that have both the possibility of prescription and without it.
Anepf, employers in the sector of drugs sold without prescription, had long been proposing such a measure. Carmen Isbert, technical director of this association, believes there is much to study about it. "The therapeutic groups must desfinanciarse completely, because if there will be no deviation of consumption." Isbert refers to a drug more specifically, the system should make the whole of which serve the same purpose. For example, "mucolytics, anti-diarrhea or artificial tears." "These are what we have always asked, but no more," he says. For example, "antitussives, laxatives or topical antivirals," he says.
The Government reserves the power to lower drug prices
It is always about treatments for "minor symptoms" and in general, cheap products. But for this "going to need a lot of negotiations," says technical director ANEFP. Because there are products that fall into one category or another depending on usage. For example, painkillers. For a headache, could be excluded from funding, but when part of chronic treatments such as arthritis, no. And so it is more likely to continue to benefit from both.
They are not the only sector to be affected. Pharmacies have an obligation to repay some of what they charge to the Administrations. This percentage depends on the level of sales. The decree limits vary. For offices that sell less, is more generous. It even includes a state contribution for selling less than 25,000 euros a month (this idea was the PSOE and is an aid to the offices of small sites). In contrast, the maximum contribution goes to the pharmacies that sell more than 600,000 euros a month, going from 15% to 27.52%.
It is not the only measure affecting the sector. The decree clarifies what has been referred to these days, Health Minister Ana Mato, when he spoke of a system of "selected price." And this is basically it is reserved the power to reduce prices of drugs or medical devices, and systems outside the reference prices.
Pharmacies that billed less will receive state aid
The text states "that the ministry will prepare a reasoned proposal" with the maximum price you're going to impose on the product. This method applies only to products for which there is reference price, ie with generic.
The system is a shaped clamp down to laboratories. And these have been resentful. Pharmacy industry, major employers in the sector, "regrets that once again the brunt of the same will be borne by the pharmaceutical industry." Public expenditure on drugs amounts to about 15,000 million euros a year, and, as calculated by the Minister of Health, is expected to save about 3,000 million under this heading.
Like a concession to the sector, the decree clarifies rather than with the prescription by active ingredient approved by the previous government was not clear. And is that physicians may, in some cases, prescribe drugs for their brand. There will be only one condition: that is the cheapest of equivalents. Especially indicated the usefulness of this in chronic patients who have already started treatment, as this prevents the drug change their appearance, and makes it easier to take it the right way.
Anepf, employers in the sector of drugs sold without prescription, had long been proposing such a measure. Carmen Isbert, technical director of this association, believes there is much to study about it. "The therapeutic groups must desfinanciarse completely, because if there will be no deviation of consumption." Isbert refers to a drug more specifically, the system should make the whole of which serve the same purpose. For example, "mucolytics, anti-diarrhea or artificial tears." "These are what we have always asked, but no more," he says. For example, "antitussives, laxatives or topical antivirals," he says.
The Government reserves the power to lower drug prices
It is always about treatments for "minor symptoms" and in general, cheap products. But for this "going to need a lot of negotiations," says technical director ANEFP. Because there are products that fall into one category or another depending on usage. For example, painkillers. For a headache, could be excluded from funding, but when part of chronic treatments such as arthritis, no. And so it is more likely to continue to benefit from both.
They are not the only sector to be affected. Pharmacies have an obligation to repay some of what they charge to the Administrations. This percentage depends on the level of sales. The decree limits vary. For offices that sell less, is more generous. It even includes a state contribution for selling less than 25,000 euros a month (this idea was the PSOE and is an aid to the offices of small sites). In contrast, the maximum contribution goes to the pharmacies that sell more than 600,000 euros a month, going from 15% to 27.52%.
It is not the only measure affecting the sector. The decree clarifies what has been referred to these days, Health Minister Ana Mato, when he spoke of a system of "selected price." And this is basically it is reserved the power to reduce prices of drugs or medical devices, and systems outside the reference prices.
Pharmacies that billed less will receive state aid
The text states "that the ministry will prepare a reasoned proposal" with the maximum price you're going to impose on the product. This method applies only to products for which there is reference price, ie with generic.
The system is a shaped clamp down to laboratories. And these have been resentful. Pharmacy industry, major employers in the sector, "regrets that once again the brunt of the same will be borne by the pharmaceutical industry." Public expenditure on drugs amounts to about 15,000 million euros a year, and, as calculated by the Minister of Health, is expected to save about 3,000 million under this heading.
Like a concession to the sector, the decree clarifies rather than with the prescription by active ingredient approved by the previous government was not clear. And is that physicians may, in some cases, prescribe drugs for their brand. There will be only one condition: that is the cheapest of equivalents. Especially indicated the usefulness of this in chronic patients who have already started treatment, as this prevents the drug change their appearance, and makes it easier to take it the right way.
衛生的な調整
重篤な症状のための薬はすぐに調達するのをやめる
下剤、粘液溶解薬といくつかの鎮痛剤を越えた位置にある業界の不安
健康に関する法令のすべての措置
エミリオ·デ·ベニート·マドリード24 ABR 2012 - 22時02分CET
重篤な症状のための薬はすぐに調達するのをやめる
下剤、粘液溶解薬といくつかの鎮痛剤を越えた位置にある業界の不安
健康に関する法令のすべての措置
エミリオ·デ·ベニート·マドリード24 ABR 2012 - 22時02分CET
0 件のコメント:
コメントを投稿